Penn-Pfizer Partnership to Accelerate Real-World Evidence in Cancer

DESCRIPTION
Penn and Pfizer are partnering to conduct a real-world evaluation of FDA-approved targeted therapies in cancer. We are developing approaches to accelerate the use of real-world evidence in cancer care.

PEOPLE
Rebecca Hubbard, PhD; Qi Long, PhD; Sean Hennessy, PharmD, PhD; Steven Joffe, MD, MPH; Angela DeMichele, MD, MSCE;  and Justin Bekelman, MD.

PARTNERS
Pfizer, Penn Center for Pharmacoepidemiology Research and Training (CPeRT), and the Department of Biostatistics, Epidemiology and Informatics (DBEI)

IMPACT
This project is currently in progress.

FUNDING
Pfizer

FOCUS
Clinical Transformation